Population Pharmacokinetics of Semaglutide for Type 2 Diabetes

INTRODUCTION: The aim of the present analysis was to characterise the absorption, distribution and elimination of semaglutide by means of population pharmacokinetic (PK) models using data from nine clinical pharmacology trials conducted in both healthy subjects and those with type 2 diabetes. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Overgaard, Rune V., Delff, Philip H., Petri, Kristin C. C., Anderson, Thomas W., Flint, Anne, Ingwersen, Steen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437231/
https://www.ncbi.nlm.nih.gov/pubmed/30788808
http://dx.doi.org/10.1007/s13300-019-0581-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437231/
https://www.ncbi.nlm.nih.gov/pubmed/30788808
http://dx.doi.org/10.1007/s13300-019-0581-y

Ejemplares similares